Shanmuga Hospital Limited is launching its IPO, opening on February 13, 2025, and closing on February 17, 2025. The IPO is a fixed-price issue with a face value of ₹10 per share and an issue price of ₹54 per share. Investors can apply in a lot size of 2,000 shares. The total issue size consists of 38,18,000 fresh issue shares, aggregating up to ₹20.62 crore. The IPO will be listed on the BSE SME platform.
The tentative allotment date is February 18, 2025, with refunds initiated on February 19, 2025. Shares will be credited to demat accounts on the same day, and the tentative listing date is February 20, 2025. Retail investors can apply for a minimum of one lot (2,000 shares) amounting to ₹1,08,000, while HNIs must apply for at least two lots (4,000 shares) amounting to ₹2,16,000.
Shanmuga Hospital Limited, incorporated in 2020, is a multispecialty hospital equipped with advanced healthcare technology. With a capacity of 151 beds, the hospital serves the medical needs of the community and patients from nearby regions. Accredited by NABH and NABL, it is committed to providing high-quality healthcare services, including prevention, treatment, and rehabilitation.
Located at 51/24 Saradha College Road, Salem, Tamil Nadu, the hospital spans 45,311 square feet across two blocks and three floors, offering both inpatient (IPD) and outpatient (OPD) services with a dedicated medical team.
The hospital operates various units, including Shanmuga Pharmacy & Diagnostics, which provides medications to both OPD and IPD patients and offers reliable pathology services for accurate medical evaluations. Additionally, Shanmuga Clinics extend specialized consultations and treatments in Salem, ensuring critical patients receive advanced care at the main hospital when needed.
Shanmuga Hospital provides a range of medical services, including Oncology, General Surgery, Orthopaedics, Cardiology, General Medicine, Paediatrics & Neonatology, Neurology, Endocrinology & Diabetes, Plastic Surgery, and Respiratory Medicine.
As of August 31, 2024, the hospital had 72 doctors, comprising 9 resident doctors, 7 junior doctors, 28 senior consulting doctors, and 28 consulting visiting doctors.
IPO stands for "Initial Public Offering." It's the process through which a privately-held company becomes publicly traded by offering its shares to the general public and listing them on a stock exchange for trading. This allows the company to raise capital from investors and grants individuals and institutions the opportunity to invest in and own a portion of the company.
The life cycle of an IPO, or Initial Public Offering, begins with a company's decision to go public. It involves hiring underwriters, registering with regulatory authorities, determining the IPO price, marketing to investors, and the subscription period where investors place orders for shares. After allocation and listing, shares become publicly tradable, and the company enters the secondary market. Ongoing reporting and corporate governance are crucial as the company continues to operate as a publicly-traded entity. The IPO aims to raise capital for growth and provides investors with opportunities to trade shares in the company.
An IPO (Initial Public Offering) is when a private company goes public by selling shares to the public. Investors buy these shares, giving them ownership in the company. It's a way for companies to raise capital and expand. The process involves underwriters, regulatory filings, setting the IPO price, and marketing to investors. After the IPO, shares can be traded on a stock exchange. IPOs offer opportunities and risks, so investors should research and consider carefully.
"Upcoming IPOs" refers to initial public offerings that have been announced by private companies but have not yet occurred. These are companies that plan to go public in the near future by issuing shares to the public and listing them on a stock exchange. Investors often keep an eye on upcoming IPOs as they represent opportunities to invest in companies at their early stages of public trading, potentially capturing growth potential. These offerings are typically accompanied by significant media and investor attention as they approach their launch dates.